The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy
Author(s) -
Rob van der Pas,
Christiaan de Bruin,
Frank W.G. Leebeek,
Moniek P.M. de Maat,
D.C. Rijken,
Alberto M. Pereira,
Johannes A. Romijn,
Romana T. NeteaMaier,
A. R. M. M. Hermus,
Pierre Zelissen,
Frank H. de Jong,
A. J. van der Lely,
Wouter W. de Herder,
Steven W. J. Lamberts,
Leo J. Hofland,
Richard A. Feelders
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-2753
Subject(s) - fibrinolysis , medicine , endocrinology , partial thromboplastin time , plasminogen activator , plasminogen activator inhibitor 1 , antithrombin , hemostasis , coagulation , heparin
Cushing's disease (CD) is accompanied by an increased risk of venous thromboembolism. Surgery is the primary treatment of CD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom